It focuses on the role of ATX/LPA in NAFLD development and its progression to liver cancer as NAFLD has an increasing incidence which is associated with the increasing incidence of liver cancer. The gene discussed is ENPP2; the disease is metabolic dysfunction-associated steatotic liver disease.